Initial eGFR Changes Predict Response to Tolvaptan in ADPKD

Kidney360. 2024 Apr 1;5(4):522-528. doi: 10.34067/KID.0000000000000404. Epub 2024 Feb 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antidiuretic Hormone Receptor Antagonists* / therapeutic use
  • Female
  • Glomerular Filtration Rate* / drug effects
  • Humans
  • Male
  • Middle Aged
  • Polycystic Kidney, Autosomal Dominant* / drug therapy
  • Tolvaptan* / therapeutic use
  • Treatment Outcome

Substances

  • Tolvaptan
  • Antidiuretic Hormone Receptor Antagonists

Associated data

  • ClinicalTrials.gov/NCT00428948